Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Two-year incidence of new immune-mediated inflammatory diseases in patients with inflammatory bowel disease: A study in the AQUILES cohort].
Marín-Jiménez I, Gisbert JP, Pérez-Calle JL, García-Sánchez V, Tabernero S, García-Vicuña R, Romero C, Juliá B, Vanaclocha F, Cea-Calvo L; Investigadores del estudio AQUILES. Marín-Jiménez I, et al. Gastroenterol Hepatol. 2015 Dec;38(10):569-74. doi: 10.1016/j.gastrohep.2015.04.003. Epub 2015 May 14. Gastroenterol Hepatol. 2015. PMID: 25983283 Spanish.
Approach to toxic megacolon.
Gonzáles Lara V, Pérez Calle JL, Marín Jiménez I. Gonzáles Lara V, et al. Rev Esp Enferm Dig. 2003 Jun;95(6):422-8, 415-21. Rev Esp Enferm Dig. 2003. PMID: 12918536 Review. English, Spanish. No abstract available.
N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study.
Guijarro LG, Mate J, Gisbert JP, Perez-Calle JL, Marin-Jimenez I, Arriaza E, Olleros T, Delgado M, Castillejo MS, Prieto-Merino D, Gonzalez Lara V, Pena AS. Guijarro LG, et al. World J Gastroenterol. 2008 May 14;14(18):2851-7. doi: 10.3748/wjg.14.2851. World J Gastroenterol. 2008. PMID: 18473409 Free PMC article. Clinical Trial.
Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of response.
González-Lama Y, López-San Román A, Marín-Jiménez I, Casis B, Vera I, Bermejo F, Pérez-Calle JL, Taxonera C, Martínez-Silva F, Menchén L, Martínez-Montiel P, Calvo M, Carneros JA, López P, Mendoza JL, Milicua JM, Huerta A, Sánchez F, Abreu L, López-Palacios N, Maté J, Gisbert JP; Group for the Study of Inflammatory Bowel Diseases from Madrid (ENICMAD). González-Lama Y, et al. Gastroenterol Hepatol. 2008 Aug-Sep;31(7):421-6. doi: 10.1157/13125587. Gastroenterol Hepatol. 2008. PMID: 18783686
[The placebo effect in inflammatory bowel disease].
Marín-Jiménez I. Marín-Jiménez I. Gastroenterol Hepatol. 2009 Oct;32 Suppl 2:44-9. doi: 10.1016/S0210-5705(09)72605-6. Gastroenterol Hepatol. 2009. PMID: 19900628 Spanish.
Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab.
Taxonera C, Estellés J, Fernández-Blanco I, Merino O, Marín-Jiménez I, Barreiro-de Acosta M, Saro C, García-Sánchez V, Gento E, Bastida G, Gisbert JP, Vera I, Martinez-Montiel P, Garcia-Morán S, Sánchez MC, Mendoza JL. Taxonera C, et al. Aliment Pharmacol Ther. 2011 Feb;33(3):340-8. doi: 10.1111/j.1365-2036.2010.04531.x. Epub 2010 Dec 7. Aliment Pharmacol Ther. 2011. PMID: 21133961 Free article.
138 results